News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
255 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21720)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (335)
2 (389)
3 (283)
4 (319)
5 (131)
6 (6)
7 (4)
8 (279)
9 (329)
10 (321)
11 (307)
12 (125)
13 (3)
14 (8)
15 (254)
16 (287)
17 (204)
18 (246)
19 (94)
20 (14)
21 (3)
22 (244)
23 (272)
24 (225)
25 (255)
26 (87)
27 (4)
28 (5)
29 (233)
30 (284)
31 (251)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
BioSpace Global Roundup: Leyden Labs Secures €40 Million in Series A Financing
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
March 25, 2021
·
6 min read
·
Alex Keown
Business
Swift Fall From Grace Continues for Former COVID-19 Vaccine Czar Slaoui
In a stunning fall from grace playing out this week, former Operation Warp Speed vaccine czar, Dr. Moncef Slaoui, issued a statement Thursday morning, as news emerged that he has resigned from additional biotech posts.
March 25, 2021
·
2 min read
·
Heather McKenzie
Drug Development
Immuno-Oncology Treatments Finding Success with Combination Therapies
With oncology drugs clocking a disheartening 3.4% success rate, some good news in the field is always appreciated.
March 25, 2021
·
2 min read
·
Kate Goodwin
Career Advice
Zoom Meeting Etiquette: What You Should and Shouldn’t Do
Virtual meetings might have enhanced the ways we connect with each other but it can be really hard to communicate with someone who doesn’t know the basic Zoom meeting etiquette.
March 25, 2021
·
3 min read
·
Kymberlie Krieger
Policy
UPDATED: FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly’s Tanezumab
Three days after U.S. Food and Drug Administration staff raised safety concerns over Pfizer’s and Eli Lilly’s NGF osteoarthritis drug tanezumab, an advisory panel has also posted its own objections.
March 25, 2021
·
3 min read
·
Alex Keown
Drug Development
Meissa’s Nasal COVID-19 Vaccine Uses Codon Deoptimization for Stronger Responses
Meissa Vaccines’ intranasal live attenuated chimeric virus-based vaccine for SARS-CoV-2 (and its variants) recently was cleared for Phase I trials, which will start at the end of March.
March 25, 2021
·
4 min read
·
Gail Dutton
Business
Neuroscience Company Uncloaks to Fight Chronic Pain, Depression and More
Eliem Therapeutics emerged from stealth mode with $80 million in financing that will be used to develop therapeutics aimed at treating neuronal excitability disorders such as chronic pain, depression, epilepsy and anxiety.
March 25, 2021
·
2 min read
·
Alex Keown
Business
Lyell Completes Cutting-Edge $65 Million Cell Therapy Facility
Lyell Immunopharma announced this week that it has completed construction of a $65 million, 70,000-square-foot LyFE Manufacturing Center, which the company will use to support clinical trials and meet cell therapy manufacturing needs.
March 25, 2021
·
3 min read
·
Brandon May
Business
BioSpace Movers & Shakers, March 26
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
March 25, 2021
·
7 min read
·
Alex Keown
Leading Approaches to Extracellular Vesicles Therapies
Two financings – and a surprise stock bump – in three days for the some of the most advanced extracellular vesicle (EV) companies show investors are champing at the bit to see the technology unleashed.
March 25, 2021
·
5 min read
·
Mark Zipkin
1 of 26
Next